Category: Cancer

Mikhail Blagosklonny Seeks for Better Cancer Treatment Methods

Mikhail Blagosklonny is a researcher and a philanthropist. As a professor, Mikhail Blagosklonny wants to make sure that all people are in a position to receive quality treatment regardless of their color or political affiliation. His area of interest is in the medical and medicinal research. Mikhail Blagosklonny areas of research include the relationship between cancer and aging. Mikhail wants to understand why certain diseases are seen to be prevalent in people of a certain age. He believes that the only way out of this impasse is research. The research results and recommendations are always important and crucial to those medical students or researchers who may want to advance the area shortly.As a professor and a practitioner, Mikhail Blagosklonny has set out the goals and objectives that he intends to achieve. These include the realization of an efficient and effective cancer treatment formula that is both cheap and less excruciating as compared to the already available options. In his previous studies, Mikhail has attempted to find out how a certain cancerous cell can be removed safely from the host body without affecting other healthy cells.

According to him, the body can only recuperate if the normal body cells are untouched during the cancer treatment process.With his zeal and determination, Professor Mikhail has been able to contribute so much to the medical field. The current research findings in his topics will act as motivation to the present and future professionals in the field. Mikhail hopes that other researchers will be able to continue with the research tests right from where he stops.By so doing, the cancer treatment procedures will be available to the common man irrespective of his social and economic standing.Currently, treatment of cancer is only a preserve of the rich and mighty in the society. Aging, on the other hand, can be defined as the chances of one dying as a result of age-related circumstances. In simpler terms, these conditions are commonly known as death from natural causes. Some of the common diseases that are associated with an advanced age include heart attack, diabetes, and cancer. Different manifestations of an advanced age like menopause cannot be considered as a disease per see.

However, there is no vivid distinction between the two.As you are aware, the process of growing in age does not just spring from nowhere. It is a process that continues from the time you are born until you die. So, if aging is a scientific process, then how does the systemic hyper body functions arise? Well, for easier understanding of this concept, you need to appreciate the fact that aging at times involves an unintended continuation of the growth process in the body. In other words, aging is more of a quasi-program rather than a program in itself. It is the continuous and purposeless growth of body cells, tissues, and organs that does not stop once the growth process is complete. For instance, the blood pressure of a person increases steadily from birth to maturity, continuation after maturity leads to hypertension. Interestingly, interventions that aim at reducing the aging rates have the potential to delay cancer.

Clay Siegall and his Ambition to Treat Cancer this Decade

Anyone who has been through cancer will tell you that everything about it is just horrifying. Scientists have been looking for therapies which will help treat the disease without causing so much suffering to the patients without success. Th has been the biggest dream for Clay Siegall, the co-founder and current president of Seattle Genetics.

Seattle Genetics is a clinical trials company which is based in Seattle, Washington. Clay Siegall and his partner founded the company in 1998 with the dream of creating functional cures and mitigation measures for people with cancer. Two decades after they started, the company has had drugs approved by the FDA, and they have been listed on NASDAQ.

 

Clay says that his inspiration to work in clinical trials came from an ordeal he saw a close relative of his go through. The pain of watching helplessly as the person battled cancer gave him the resolve to one day change the situation if he could. He got his Bachelor of Science in zoology from the University of Maryland. He then proceeded to do masters and a Ph.D. in Genetics from the George Washington University. One of the drugs that were approved by the FDA in 2011 as an antibody-based cancer therapy is Adcetris.

 

He had worked in several other research companies before he left to start Seattle Genetics. Clay has been a prolific writer of science journals and is published in more than 70 of them. Besides this, he holds more than 15 patents. He says that getting to the level of success he is at right now is not simple. He revealed that there was a time when they did not even have enough funds to pay their workers’ salaries, but they still believed in their dream.

 

The drug is now on sale in more than 60 countries all over the world. He states that the next step for his company is getting the other 11 drugs they have been developing approval by the FDA. The company has been hiring more staff to make this dream a reality. Seattle Genetics’ success has been a result of Clay Siegall’s hard work and unrelenting spirit.